OnCo

Stay in the loop

Leave your email and OnCo will write when something big changes in cancer research. No spam, one click to unsubscribe.

Email updates open shortly. Until then, press Watch on any page to keep it on your list.

trialsTrialRecruiting

A Study of HRS-4642 in Combination With Antineoplastic Agents in Advanced Solid Tumors

A phase 1/2 trial of HRS-4642 in advanced solid tumours, run by Jiangsu HengRui Medicine Co., Ltd., now recruiting.